Autor: "Du KQ" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.
Autorzy:: Zhu YC; Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, China.
Zhou YF; Department of Oncology, Lishui Central Hospital, Lishui Hospital of Zhejiang University, Lishui, China.
Wang WX; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China.
Xu CW; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
Zhuang W; Department of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
Du KQ; Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, China.
Chen G; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2018 May; Vol. 9 (5), pp. 652-655. Date of Electronic Publication: 2018 Mar 08.
Typ publikacji:: Case Reports; Research Support, Non-U.S. Gov't
MeSH Terms:: Adenocarcinoma of Lung/*genetics
Microtubule-Associated Proteins/*genetics
Oncogene Proteins, Fusion/*genetics
Protein-Tyrosine Kinases/*genetics
Proto-Oncogene Proteins/*genetics
Adenocarcinoma of Lung/pathology ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Middle Aged

Raport

Skocz do pozycji: 2.

Tytuł:: Dual drive coexistence of EML4-ALK and TPM3-ROS1 fusion in advanced lung adenocarcinoma.
Autorzy:: Zhu YC; Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, China.
Liao XH; Tumor Molecular Laboratory, Zhejiang Rongjun Hospital, Jiaxing, China.
Wang WX; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China.
Xu CW; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
Zhuang W; Department of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
Wei JG; Department of Pathology, Shaoxing People's Hospital, Shaoxing, China.
Du KQ; Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2018 Feb; Vol. 9 (2), pp. 324-327. Date of Electronic Publication: 2017 Dec 18.
Typ publikacji:: Case Reports; Research Support, Non-U.S. Gov't
MeSH Terms:: Adenocarcinoma/*genetics
Lung Neoplasms/*genetics
Oncogene Proteins, Fusion/*genetics
Protein-Tyrosine Kinases/*genetics
Proto-Oncogene Proteins/*genetics
Tropomyosin/*genetics
Adenocarcinoma/pathology ; Adenocarcinoma/surgery ; Adenocarcinoma of Lung ; ErbB Receptors/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Lung Neoplasms/pathology ; Lung Neoplasms/surgery ; Male ; Middle Aged ; Mutation ; Neoplasm Staging

Raport

Informacja